Biomoda, Inc., maker of patented early lung cancer detection testing and other cancer diagnostic technology, confirmed today that it is continuing to expand its patent portfolio with a unique patent pending for the use of its patented porphyrin molecule to detect different cell variations of lung cancer. “It is important that the Company protect all the various uses of this molecule, setting up a barrier to entry for competition,” said John Cousins, President of Biomoda. “We are protecting the value of our core patents with patents that detail improvements and new uses of our strong, innovative technology. This prevents those on the periphery from attempting to target our patents with a so-called ‘picket fence’ of minor patents that could weaken our powerful market position.”

Cell Therapeutics, Inc. (CTI) today announced presentations of interest on lung cancer and on its development candidate XYOTAX(TM) (paclitaxel poliglumex) at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting, being held June 1-5, 2007, in Chicago.

Perceptronix Medical Inc. (“Perceptronix”) announced it has signed a service agreement for its LungSign(TM) test (formerly ClearSign(TM)) with University Hospital of Coventry and Warwickshire (UHCW) NHS Trust in the UK.

People who lived in Amagasaki, Hyogo Prefecture, from the 1950s through 1970s were 14 times more likely to die from asbestos-related mesothelioma than the national average, an Environment Ministry survey showed.

About 2.8 percent of lung cancer cases in the world is attributed to second-hand smoking, according to an official of the World Health Organization (WHO).

Dr. Jean Marc Olive, WHO country representative, said non-smokers are not exempted from acquiring lung cancer, one of the top causes of deaths in the Philippines and in the world.

“Breathing second-hand smoke or SHS is very dangerous to health. It causes cancer, as well as many serious respiratory and cardiovascular diseases in children and adults, often leading to death,” Olive said during the launching yesterday of the “World No Tobacco Day” on May 31.

SINGAPORE : There will soon be a new tool which can diagnose effective drugs to treat lung cancer patients in a faster and cheaper way.

Shantha Biotechnics Ltd has filed a pre-IND (investigational new drug) application with US regulators for permission to carry out Phase-I clinical trials on human monoclonal antibodies to treat lung cancer. If cleared, it will be the first trial by an Indian company in the US.

People living near arsenic-tainted Swann Park wonder if their loved ones’ poor health or deaths are tied to working at a once-nearby factory. And they wonder if they’re next.

If our smog doesn’t rot your lungs, the sun shining through may attack your skin.

Lung and skin cancer rates in the Great Lakes region, the province’s smog belt, are higher than Ontario averages.

Side by side and stride by stride, two devoted daughters and best friends will demonstrate their love for their fathers and their commitments to fighting the lung diseases that killed one’s father and is threatening the other’s. The two will walk and bike this holiday weekend for more than 130 miles in the Bay area over four days to raise money and awareness for Idiopathic Pulmonary Fibrosis (IPF) and lung cancer.